Trial intelligence / Profile preview

PURETHAL Bee vs Alutard SQ Bee for honeybee venom allergy

2005-002859-41Phase 3Completed

Sponsor
HAL Allergy Group
Start
Aug 2005
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of honey bee hymenoptera venom in Honey bee venom allergy (HBVA) (2 arms), sponsored by HAL Allergy Group. Primary endpoint: Systemic reactions to re-sting. Started Aug 2005; status: completed.

02

Drugs

honey bee hymenoptera venom
03

Conditions

Honey bee venom allergy (HBVA)

Beyond the preview

Go deeper on 2005-002859-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002859-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call